NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
Key Facts
Status: Forecasted
Posted date: November 12, 2024
Archive date: October 11, 2027
Close date: September 5, 2027
Opportunity ID: 357073
Opportunity number: PAR-25-133
Opportunity category: Discretionary
Agency name: National Institutes of Health
Agency code: HHS-NIH11
Award floor: $0
Award ceiling: $0
Cost sharing required: No
Funding Instrument Types
- Cooperative Agreement
Category of Funding Activity
- Health
Eligible Applicants
- Small businesses
Tools
Categories (use these for quoted searches)
- agency_code:hhs_nih11
- category_of_funding_activity:health
- cost_sharing_or_matching_requirement:false
- eligible_applicants:small_businesses
- funding_instrument_type:cooperative_agreement
- opportunity_category:discretionary
- status:forecasted
Description
This announcement encourages small business applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing clinical studies. Diseases chosen for study should be based on the NINDS strategic plan and clinical research interests (www.ninds.nih.gov/funding/areas/index.htm).